Orbit Discovery

Oxford, United Kingdom Founded: 2015 • Age: 11 yrs
Drug discovery platform developed using peptide display engine.
Annual revenue - Latest available
Total funding $15.7M 4 rounds
Employees 26 Tracked headcount
Investors 9 Known backers
Products 3 Services tracked
Competitors 10 Brand Intelligence

About Orbit Discovery

Orbit Discovery is a company based in Oxford (United Kingdom) founded in 2015. Orbit Discovery has raised $15.73 million across 4 funding rounds from investors including Oxford Technology, Oxford University Innovation and Innovate UK. The company has 26 employees as of December 31, 2020. Orbit Discovery offers products and services including Bead-based Display System, Microfluidics Screening, and Peptide Conjugate Services. Orbit Discovery operates in a competitive market with competitors including AbSci, Antiverse, LabGenius, Ordaos and immunitoAI, among others.

  • Headquarter Oxford, United Kingdom
  • Employees 26 as on 31 Dec, 2020
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Orbit Discovery Ltd
  • Date of Incorporation 01 Sep, 2020
  • Jurisdiction OXFORD, OXFORDSHIRE, UNITED KINGDOM
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $15.73 M (USD)

    in 4 rounds

  • Latest Funding Round
    $580.97 K (USD), Grant

    Jun 13, 2022

  • Investors
  • Employee Count
    26

    as on Dec 31, 2020

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Orbit Discovery

Orbit Discovery offers a comprehensive portfolio of products and services, including Bead-based Display System, Microfluidics Screening, and Peptide Conjugate Services.

Product name locked
Category locked
Primary

High-throughput platform for peptide discovery and affinity screening

Product name locked
Category locked
Locked

System for direct functional testing of peptides in therapeutic applications

Product name locked
Category locked
Locked

Services for identifying peptide ligands for targeted drug delivery

People of Orbit Discovery

Headcount 10-50
Employee Profiles 20
Employee Profiles
People
Gillian Donachie
Operations Manager
People
Neil Butt
CEO
People
Xiaoju Ni
Principal Scientist, Team lead
People
Mark Peacock
Research And Development Scientist II

Unlock access to complete

Funding Insights of Orbit Discovery

Orbit Discovery has successfully raised a total of $15.73M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $580.97 thousand completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Orbit Discovery

Orbit Discovery has secured backing from 9 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Oxford Technology, Oxford University Innovation and Innovate UK.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
Investment management services for science ventures are provided in Oxford.
Locked Locked Locked
Venture capital firm investing in seed & series A startups
Locked Locked Locked
Startups are incubated by Oxford University Innovation.
Locked Locked Locked
Premium access

Investor details for Orbit Discovery

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Orbit Discovery

Investments
Premium access

Investment portfolio details for Orbit Discovery

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Orbit Discovery

Premium access

Detailed financials for Orbit Discovery

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Orbit Discovery Comparisons

Orbit Discovery Primary company
Description
Drug discovery platform developed using peptide display engi...
Location
Oxford, United Kingdom
Founded Year
2015
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
26
As of 2020
Premium access

Peer comparison for Orbit Discovery

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Orbit Discovery

Orbit Discovery operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AbSci, Antiverse, LabGenius, Ordaos and immunitoAI, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
AI-based technology is used for recombinant protein production in therapeutics.
Locked Locked Locked
An AI platform for antibody drug discovery is provided.
Locked Locked Locked
AI-driven platform for discovering and optimizing therapeutic antibodies for treatments.
Locked Locked Locked
AI accelerator provided for biomedical research and drug discovery.
Locked Locked Locked
An AI-based platform for antibody discovery and therapeutics is developed.
Premium access

Detailed competitors of Orbit Discovery

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Orbit Discovery

Premium access

Complete news archive for Orbit Discovery

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Orbit Discovery

Orbit Discovery was founded in 2015 and raised its 1st funding round 1 year after it was founded.

Orbit Discovery is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.

Neil Butt is the current CEO of Orbit Discovery.

Orbit Discovery is a funded company, having raised a total of $15.73M across 4 funding rounds to date.

As of Dec 31, 2020, the latest employee count at Orbit Discovery is 26.

Developer of a drug discovery platform by the peptide display engine. The technology uses phage display to find novel natural peptides and present it to the desired target and mRNA display for natural peptides. It has a DNA library that encodes for the peptides and each DNA is attached to a single bead, after a long process of emulsion PCR, transcription, and translation the synthesized peptides are presented to the target for screening.

Orbit Discovery's top competitors include Antiverse, AbSci and Ordaos.

Orbit Discovery offers Bead-based Display System, Microfluidics Screening, and Peptide Conjugate Services.

Orbit Discovery has 9 investors. Key investors include Oxford Technology, Oxford University Innovation, Innovate UK, Oxford Science Enterprises, and Borealis Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available